Center-Authored Papers

Filters: Author is Rolland, Morgane  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Dommaraju K, Kijak G, Carlson JM, Larsen BB, Tovanabutra S, Geraghty DE, Deng W, Maust BS, Edlefsen PT, Sanders-Buell E et al..  2014.  CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.. PloS one. 9(10):e111334. Abstract
E
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, Decamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M et al..  2015.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.. PLoS computational biology. 11(2):e1003973. Abstract
Edlefsen PT, Gilbert PB, Rolland M.  2013.  Sieve analysis in HIV-1 vaccine efficacy trials.. Current opinion in HIV and AIDS. Abstract
H
Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, Wong K, Stoddard JN, Raugi D, Sorensen S et al..  2011.  Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.. Journal of virology. 85(15):7523-34. Abstract
J
Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, Hural J, Corey L, Self SG, Buchbinder SP et al..  2015.  HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders.. Nature medicine. Abstract
Janes H, Frahm N, DeCamp A, Rolland M, Gabriel E, Wolfson J, Hertz T, Kallas E, Goepfert P, Friedrich DP et al..  2012.  MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load.. PloS one. 7(8):e43396. Abstract
L
Liu Y, McNevin J, Rolland M, Zhao H, Deng W, Maenza J, Stevens CE, Collier AC, McElrath MJ, Mullins JI.  2009.  Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.. The Journal of infectious diseases. 200(12):1825-33. Abstract
P
Prentice HA, Tomaras GD, Geraghty DE, Apps R, Fong Y, Ehrenberg PK, Rolland M, Kijak GH, Krebs SJ, Nelson W et al..  2015.  HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.. Science translational medicine. 7(296):296ra112. Abstract
R
Rolland M, Manocheewa S, Swain VJ, Lanxon-Cookson EC, Kim M, Westfall DH, Larsen BB, Gilbert PB, Mullins JI.  2013.  HIV-1 conserved elements vaccines: Relationship between sequence conservation and replicative capacity.. Journal of virology. Abstract
Rolland M, Gilbert P.  2012.  Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.. AIDS research and human retroviruses. 28(4):400-4. Abstract
Rolland M, Frahm N, Nickle DC, Jojic N, Deng W, Allen TM, Brander C, Heckerman DE, Mullins JI.  2011.  Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences.. PloS one. 6(3):e17969. Abstract
Rolland M, Tovanabutra S, Decamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A et al..  2011.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.. Nature medicine. 17(3):366-71. Abstract
Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, Decamp AC, Carrico C, Menis S, Magaret CA et al..  2012.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.. Nature. 490(7420):417-20. Abstract
S
Sunshine JE, Larsen BB, Maust B, Casey E, Deng W, Chen L, Westfall DH, Kim M, Zhao H, Ghorai S et al..  2015.  Fitness-balanced escape determines resolution of dynamic founder virus escape processes in HIV-1 infection.. Journal of virology. Abstract
Z
Zolla-Pazner S, Edlefsen PT, Rolland M, Kong X-P, DeCamp A, Gottardo R, Williams C, Tovanabutra S, Sharpe-Cohen S, Mullins JI et al..  2014.  Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses.. EBioMedicine. 1(1):37-45. Abstract